← All diseases
Cancer
Glioblastoma
Would you like to receive a message when there is new research about Glioblastoma? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Glioblastoma. View what Premium costs.
Publications and studies (2295)
- LASSO-based screening for potential prognostic biomarkers associated with glioblastoma. (2023/01/16) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent advances in ferroptosis and therapeutic strategies for glioblastoma. (2023/01/13) ♡
- Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme. (2023/01/12) ♡
- TREM2 is associated with tumor immunity and implies poor prognosis in glioma. (2023/01/11) ♡
- DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma. (2023/01/11) ♡
- Dimorphic glioblastoma with glial and epithelioid phenotypes: Clonal evolution and immune selection. (2023/01/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Natural killer cell therapy potentially enhances the antitumor effects of bevacizumab plus irinotecan in a glioblastoma mouse model. (2023/01/10) ♡
- Survival prediction for patients with glioblastoma multiforme using a Cox proportional hazards denoising autoencoder network. (2023/01/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Response and resistance to BRAF(V600E) inhibition in gliomas: Roadblocks ahead? (2023/01/09) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Chemokine-like factor-like MARVEL transmembrane domain containing 6: Bioinformatics and experiments in vitro analyze in glioblastoma multiforme. (2023/01/09) ♡
- Effectiveness and safety of tumor-treating fields therapy for glioblastoma: A single-center study in a Chinese cohort. (2023/01/09) ♡
- TSPAN4 is a prognostic and immune target in Glioblastoma multiforme. (2023/01/06) ♡
- Fc gamma receptor IIb in tumor-associated macrophages and dendritic cells drives poor prognosis of recurrent glioblastoma through immune-associated signaling pathways. (2023/01/06) ♡
- Transcriptome and single-cell analysis reveal the contribution of immunosuppressive microenvironment for promoting glioblastoma progression. (2023/01/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of cell membrane-coated nanoparticles as a novel treatment approach in glioblastoma. (2023/01/04) ♡
- Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2(+)/CX3CR1(+) M-MDSCs into the tumor microenvironment in a redundant manner. (2023/01/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Implications of BRAF V600E mutation in gliomas: Molecular considerations, prognostic value and treatment evolution. (2023/01/04) ♡
- MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme. (2023/01/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region. (2023/01/04) ♡
- A data assimilation framework to predict the response of glioma cells to radiation. (2023/01/01) ♡
- Endocytosis of AMPA receptors: Role in neurological conditions. (2023/01/01) ♡
- Effectiveness of 6D couch with daily cone beam computed tomography in reducing PTV margins for glioblastoma multiforme. (2023/01/01) ♡
- High throughput-screening of native herbal compounds identifies taccaoside A as a cytotoxic compound that mediates RAS signaling in cancer stem cells. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Relationship between the therapeutic potential of various plant-derived bioactive compounds and their related microRNAs in neurological disorders. (2023/01/01) ♡
- [Effect of Morus alba extract sanggenon C on growth and proliferation of glioblastoma cells]. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives. (2023/01/01) ♡
- Global and Regional DNA methylation silencing of PPARγ Associated with Glioblastoma Multiforme Pathogenesis. (2023/01/01) ♡
- Alocasia odora-mediated synthesis of silver nanoparticles, their cytotoxicity, and virucidal potential. (2023/01/01) ♡
- Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel. (2023/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The use of MR perfusion parameters in differentiation between glioblastoma recurrence and radiation necrosis. (2023/01/01) ♡
- Camboginol and Morelloflavone from Garcinia dulcis (Roxb.) Kurz Flower Extract Promote Autophagic Cell Death against Human Glioblastoma Cells through Endoplasmic Reticulum Stress. (2022/12/31) ♡
- Pneumocystis jirovecii pneumonia and deep vein thrombosis in a patient with glioblastoma multiforme. (2022/12/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Rare Case of Extracranial Metastases in a Patient with IDH-Mutant Glioblastoma. (2022/12/31) ♡
- Clinical utility of serum glial fibrillary acidic protein in glial neoplasm. (2022/12/30) ♡
- Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study. (2022/12/29) ♡
- Multiparametric Magnetic Resonance Imaging Correlates of Isocitrate Dehydrogenase Mutation in WHO high-Grade Astrocytomas. (2022/12/29) ♡
- Optimal Design of a Multipole-Electromagnet Robotic Platform for Ophthalmic Surgery. (2022/12/29) ♡
- HLA-A, HSPA5, IGFBP5 and PSMA2 Are Restriction Factors for Zika Virus Growth in Astrocytic Cells. (2022/12/29) ♡
- Evaluation of the Cytotoxicity of Cationic Polymers on Glioblastoma Cancer Stem Cells. (2022/12/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Delayed, Progressive Multivessel Occlusion After Resection of a Recurrent Glioma. (2022/12/27) ♡
- Positive Expression of Retinol-Binding Protein 4 Is Related to the Malignant Clinical Features Leading to Poor Prognosis of Glioblastoma. (2022/12/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery. (2022/12/24) ♡
- Optimizing maximum resection of glioblastoma: Raman spectroscopy versus 5-aminolevulinic acid. (2022/12/23) ♡
- Potential glioblastoma biomarkers identified by mass spectroscopy and iTRAQ labeling. (2022/12/23) ♡
- Cuscuta epithymum Murr. crude extract pre-conditioning protects C6 cells from L-glutamate-induced neurotoxicity. (2022/12/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. FLVCR1-AS1 and FBXL19-AS1: Two Putative lncRNA Candidates in Multiple Human Cancers. (2022/12/22) ♡
- Intranasal Delivery of Liposomes to Glioblastoma by Photostimulation of the Lymphatic System. (2022/12/22) ♡
- Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma. (2022/12/22) ♡
- Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. (2022/12/21) ♡
- Combination of a Chaperone Synthesis Inducer and an Inhibitor of GAPDH Aggregation for Rehabilitation after Traumatic Brain Injury: A Pilot Study. (2022/12/20) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.